t:slim X2 insulin pumps

  • Potential speaker-related issue that can trigger an error resulting in a discontinuation of insulin delivery
  • Company: Tandem Diabetes Care, Inc.
  • Medical Devices
  • FDA
  • August 7, 2025

Product details

  • t:slim X2 insulin pumps

Company announcement

Tandem Diabetes Care, Inc. announced a voluntary medical device correction for select t:slim X2 insulin pumps due to a potential speaker-related issue.

The issue can trigger an error, Malfunction 16, resulting in a discontinuation of insulin delivery.

Impacted customers in the United States were notified between July 22 and 24, 2025.

59 injuries have been reported.

Risk:

If not addressed, this could result in hyperglycemia due to discontinuation of insulin delivery, real-time CGM Estimated Glucose Values, and CGM trends. In severe cases of hyperglycemia, the user may require hospitalization or intervention from a medical professional.

Impacted states: Nationwide

Products:

- t:slim X2 insulin pumps

Contact

For more information, call (877) 801-6901 or email techsupport@tandemdiabetes.com.

View the original FDA notice

Browse all recalls

Related recalls